Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors.
Jennifer L. Leddon(University of Cincinnati), Trisha M. Wise‐Draper(University of Cincinnati), Arushi Agrawal(University of Cincinnati), Martina Chirra(University of Cincinnati), Vinita Takiar(University of Cincinnati), Timothy Stone(University of Cincinnati), Roman Jandarov(University of Cincinnati), Logan Roof(University of Cincinnati), Hira Shaikh(University of Iowa Hospitals and Clinics), Danny Trotier(University of Cincinnati)
Cited by 0
Related Papers
Mre11 Nuclease Activity Has Essential Roles in DNA Repair and Genomic Stability Distinct from ATM Activation
|Cell|2008|341
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328
Covalently Linked Au Nanoparticles to a Viral Vector: Potential for Combined Photothermal and Gene Cancer Therapy
|Nano Letters|2006|260
Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses
|International Journal of Radiation Oncology*Biology*Physics|2016|149
Going back to class I: MHC and immunotherapies for childhood cancer
|Pediatric Blood & Cancer|2014|86